Statement of no deviation or variation as per Regulation 32 of the SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Desh Rakshak Aushdhalaya Limited, a Haridwar-based Ayurvedic and herbal products maker (BSE scrip code 531521), has filed a quarterly compliance statement confirming that funds raised through a preferential issue have been used as originally intended, with no deviation. The company had raised Rs. 2.77 crore on September 9, 2025 by allotting 12.60 lakh equity shares at Rs. 22 each (Rs. 10 face value plus Rs. 12 premium) to qualified investors on a preferential basis. As of December 31, 2025, Rs. 2.07 crore was utilised towards working capital requirements (against an allocation of Rs. 2.078 crore), and Rs. 69.30 lakh was fully utilised for general corporate purposes. The audit committee reviewed and approved the statement at its meeting on February 13, 2026.
This is a routine regulatory compliance filing and is largely neutral for shareholders. It signals disciplined use of the recently raised funds, with nearly the entire Rs. 2.77 crore already deployed as planned, which is a mildly positive sign of management execution but unlikely to move the stock price meaningfully.